Atai Life Sciences N. V. , through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company.
Atai Life Sciences Nv stock last closed at $1.23, down 1.6% from the previous day, and has decreased 14.58% in one year. It has underperformed other stocks in the Biotechnology industry by 0.03 percentage points. Atai Life Sciences Nv stock is currently +20% from its 52-week low of $1.03, and -56.84% from its 52-week high of $2.85.
As of Sep 12, 2024, there are 167.8M ATAI shares outstanding. The market cap of ATAI is $206.39M. In the last 24 hours, 333,603 ATAI shares were traded.
How to Buy Atai Life Sciences Nv Stock
Wondering how to invest in Atai Life Sciences Nv stock? Here's how.
Figure out where to buy Atai Life Sciences Nv stock: You need to pick an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you decide where to buy Atai Life Sciences Nv stock.
Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Fund your brokerage account: Pick your payment method and add your information.
Analyze Atai Life Sciences Nv stock: The Atai Life Sciences Nv ticker symbol is ATAI. Is Atai Life Sciences Nv stock a good investment? Should you buy shares of ATAI? How do ATAI's underlying business fundamentals look? Do top analysts think Atai Life Sciences Nv is a good buy? Why has ATAI's stock price moved recently? (Hint: Our stock market research website can help you decide if ATAI is a good stock to buy).
Execute your ATAI trade: Decide if you will purchase ATAI shares at the current market price or use a limit order to buy ATAI stock at a specific price.
Watch your ATAI investment: Create a watchlist to watch your investment in Atai Life Sciences Nv shares.
Step 1: Figure out where to buy Atai Life Sciences Nv stock
You need an online brokerage account in order to access the NASDAQ market and buy ATAI stock.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to global markets: From Technology to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal details so you are able to invest in ATAI stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Atai Life Sciences Nv stock
After you have figured out the best place to buy Atai Life Sciences Nv stock, it's important to analyze their stock before you invest, so you actually wrap your head around the risk as well as the upside.
Atai Life Sciences Nv Metrics
ATAI Price
$1.23
1w %
0.82%
1y %
-14.58%
5y %
N/A
P/E
-3.42x
P/B
1.23x
P/S
615x
PEG
N/A
Revenue
$378.00k
Earnings
-$58.07M
Fore. Rev. Growth
56.54%
Fore. Earn. Growth
N/A
Market Cap
$206.39M
Next Earnings
Nov 5, 2024
Next Dividend
N/A
ATAI Due Diligence Checks
WallStreetZen was built to help everyday investors do more accurate fundamental analysis in less time.
Last year, ATAI revenue was $378.00k. Over the past three year, ATAI's revenue has gone up by -99.36% per year. This was slower than the Biotechnology industry average of 55.29%.
What are ATAI executives and large shareholders up to?
Over the past year, executives and large shareholders at ATAI have sold more shares than they have bought.
Florian Brand, Co-Founder Chief Executive Officer of ATAI, was the latest ATAI insider to sell. They sold $290,501.76 worth of ATAI shares on May 16, 2024.
No, Atai Life Sciences Nv doesn't provide an income stream by paying out dividends.
ATAI Social Trading Data
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your ATAI trade
You have two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually the easiest way to buy.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at a given dollar amount, use a limit order.
Hit the Open button and eToro will place your order.
If you want additional help investing in stocks on eToro, click the helpful video below:
How much does it cost to buy one Atai Life Sciences Nv share?
As of Sep 12, 2024, it costs $1.23 to buy one share of Atai Life Sciences Nv stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.62, you can buy 0.5 shares of ATAI.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.